is retatrutide more expensive than tirzepatide vs Retatrutide: The Future of Weight Loss Therapies 🔹 Tirzepatide (Mounjaro/Zepbound) • Dual agonist: GLP‑1 + GIP • FDA‑approved (2022–2023) • Avg. weight loss: ~21% at 72 weeks • Widely available Difference between tirzepatide and retatrutide:

Same percentage, different number on the scale

2024;385:e078242

It has the largest Trustpilot review volume in the category

This slow climb continues only as needed, potentially reaching higher doses like 10 mg or 15 mg

As the popularity of these drugs continues to increase, the healthcare industry is looking at ways of reducing costs

Researchers said weight regain has been reported after stopping other obesity medications, and overall data confirm the chronicity of obesity and highlight the importance of maintaining long-term pharmacological treatment for weight management in people with obesity. The success of GLP-1 medications can depend on how long people use them